−0.035AUD
−6.25 MAUD
4.24 MAUD
161.52 M
About ORTHOCELL LIMITED
Sector
Industry
CEO
Paul Frederick Anderson
Website
Headquarters
Murdoch
Founded
2006
ISIN
AU000000OCC6
FIGI
BBG006N6HL75
Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. Its products include CelGro, which is a naturally derived collagen medical device for soft tissue repair; and Antilogous Tenocyte Implantation for chronic treatment resistant tendon injuries. The company was founded by Paul Frederick Anderson and Ming Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OCC is 0.380 AUD — it has increased by 1.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ORTHOCELL LIMITED stocks are traded under the ticker OCC.
ORTHOCELL LIMITED is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
OCC stock is 2.67% volatile and has beta coefficient of 0.90. Check out the list of the most volatile stocks — is ORTHOCELL LIMITED there?
ORTHOCELL LIMITED revenue for the last quarter amounts to 846.86 K AUD despite the estimated figure of 2.00 M AUD. In the next quarter revenue is expected to reach 2.20 M AUD.
Yes, you can track ORTHOCELL LIMITED financials in yearly and quarterly reports right on TradingView.
OCC stock hasn't changed in a week, the month change is a 6.17% fall, over the last year ORTHOCELL LIMITED has showed a 6.17% decrease.
OCC net income for the last quarter is −5.23 M AUD, while the quarter before that showed −2.19 M AUD of net income which accounts for −138.64% change. Track more ORTHOCELL LIMITED financial stats to get the full picture.
Today ORTHOCELL LIMITED has the market capitalization of 79.54 M, it has increased by 4.00% over the last week.
No, OCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORTHOCELL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORTHOCELL LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORTHOCELL LIMITED stock shows the sell signal. See more of ORTHOCELL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ORTHOCELL LIMITED future price: according to them, OCC price has a max estimate of 1.00 AUD and a min estimate of 1.00 AUD. Read a more detailed ORTHOCELL LIMITED forecast: see what analysts think of ORTHOCELL LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORTHOCELL LIMITED EBITDA is −10.37 M AUD, and current EBITDA margin is −229.92%. See more stats in ORTHOCELL LIMITED financial statements.